Hongle X. Li

127 Dongming Road
Zhengzhou, 450008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

WDR5-H3K4me3 Epigenetic Axis Promotes TRMT6-Dependent tRNA M1A Modification to Facilitate Triple-Negative Breast Cancer Progression by Suppressing Ferroptosis.

WDR5-H3K4me3 Epigenetic Axis Promotes TRMT6-Dependent tRNA M1A Modification to Facilitate Triple-Negative Breast Cancer Progression by Suppressing Ferroptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 04, 2025

STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinoma.

STBD1 mediates the crosstalk between glycogen and lipid droplets in clear cell renal cell carcinoma.

Journal: Cell reports

Published: February 17, 2025

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis.

The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis.

Journal: The Journal of biological chemistry

Published: December 17, 2024

CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1.

CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1.

Journal: Cellular & molecular biology letters

Published: August 06, 2024

A comparative study of sampling methods in the detection of esophageal cancer-related microbiota.

A comparative study of sampling methods in the detection of esophageal cancer-related microbiota.

Journal: Microbiology spectrum

Published: July 09, 2024

METTL1-mediated tRNA m7G methylation and translational dysfunction restricts breast cancer tumorigenesis by fueling cell cycle blockade.

METTL1-mediated tRNA m7G methylation and translational dysfunction restricts breast cancer tumorigenesis by fueling cell cycle blockade.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 18, 2024

Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis.

Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis.

Journal: Cancer biology & medicine

Published: October 11, 2023

N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming.

N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming.

Journal: Cell death & disease

Published: May 25, 2023

An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model.

An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model.

Journal: The Journal of clinical investigation

Published: May 09, 2023

EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression.

EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression.

Journal: Cell death & disease

Published: March 11, 2023

When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities.

When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities.

Journal: Cancer letters

Published: February 14, 2023

IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis.

IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 05, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026